Page last updated: 2024-10-22

alendronate and Sclerosis

alendronate has been researched along with Sclerosis in 4 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bereket, A1
Erdogan, T1
Hayami, T1
Pickarski, M1
Wesolowski, GA1
McLane, J1
Bone, A1
Destefano, J1
Rodan, GA1
Duong, LT1
Yu, Z1
Funayama, H1
Deng, X1
Kuroishi, T1
Sasano, T1
Sugawara, S1
Endo, Y1
Damiani, D1

Other Studies

4 other studies available for alendronate and Sclerosis

ArticleYear
Oral bisphosphonate therapy for vitamin D intoxication of the infant.
    Pediatrics, 2003, Volume: 111, Issue:4 Pt 1

    Topics: Administration, Oral; Alendronate; Bone Diseases; Hand; Humans; Hypercalcemia; Iatrogenic Disease; I

2003
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:4

    Topics: Acid Phosphatase; Alendronate; Animals; Anterior Cruciate Ligament; Bone Remodeling; Calcinosis; Car

2004
Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
    Basic & clinical pharmacology & toxicology, 2005, Volume: 97, Issue:4

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density Conservation Agents; Clodronic

2005
Metaphyseal sclerosis associated with bisphosphonate therapy.
    Journal of pediatric endocrinology & metabolism : JPEM, 2007, Volume: 20, Issue:11

    Topics: Alendronate; Bone and Bones; Bone Density Conservation Agents; Dermatomyositis; Diphosphonates; Huma

2007